DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 30566-92-8, 5-(n,n-dibenzylglycyl)salicylamide, 5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide, 5-((bis(benzyl)amino)acetyl)salicylamide, Einecs 250-244-9, Ec 250-244-9

Molecular Formula

C₂₃H₂₂N₂O₃

Molecular Weight

374.4 g/mol

InChI Key

DNLPQXRWAKCKPX-UHFFFAOYSA-N

1 2D Structure

5-N,N-Dibenzylglycyl-Salicylamide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide

2.1.2 InChI

InChI=1S/C23H22N2O3/c24-23(28)20-13-19(11-12-21(20)26)22(27)16-25(14-17-7-3-1-4-8-17)15-18-9-5-2-6-10-18/h1-13,26H,14-16H2,(H2,24,28)

2.1.3 InChI Key

DNLPQXRWAKCKPX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC=C(C=C1)CN(CC2=CC=CC=C2)CC(=O)C3=CC(=C(C=C3)O)C(=O)N

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 30566-92-8

2. 5-(n,n-dibenzylglycyl)salicylamide

3. 5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide

4. 5-((bis(benzyl)amino)acetyl)salicylamide

5. Einecs 250-244-9

6. Ec 250-244-9

7. Mls006010007

8. Schembl11197070

9. Amy8802

10. Dtxsid40184651

11. 5-(n,n-dibenzylglcyl)salicylamide

12. 5-(n,n-dibenzylglycyl) Salicylamide

13. Zinc19943219

14. 5-(dibenzylglycyl)-2-hydroxybenzamide

15. Akos015901102

16. Sb83717

17. Dibenzylamino)acetyl)-2-hydroxybenzamide

18. 5-[2-(dibenzylamino)acetyl]salicylamide

19. Smr004701089

20. Cs-0450761

21. Ft-0619916

22. W-106934

23. 5-[[bis(phenylmethyl)amino]acetyl]-2-hydroxybenzamide

2.3 Create Date

2005-07-19

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₂₂N₂O₃
Molecular Weight	374.4 g/mol
XLogP3	3.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	8
Exact Mass	374.16304257 g/mol
Monoisotopic Mass	374.16304257 g/mol
Topological Polar Surface Area	83.6 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	492
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1